Ruane, Cunniff & Goldfarb’s Merck MRK Stock Holding History

Ruane, Cunniff & Goldfarb’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,172	Closed	-$229K	–	107
2016 Q2	$229K	Sell	4,172 -957	-19%	-$50.9K	﹤0.01%	111
2016 Q1	$259K	Sell	5,129 -105	-2%	-$5.14K	﹤0.01%	127
2015 Q4	$264K	Hold	5,234	–	–	﹤0.01%	136
2015 Q3	$247K	Buy	5,234 +220	+4%	+$11.7K	﹤0.01%	139
2015 Q2	$272K	Hold	5,014	–	–	﹤0.01%	133
2015 Q1	$275K	Hold	5,014	–	–	﹤0.01%	137
2014 Q4	$272K	Hold	5,014	–	–	﹤0.01%	137
2014 Q3	$284K	Buy	5,014 +184	+4%	+$10.3K	﹤0.01%	141
2014 Q2	$267K	Buy	4,830 +209	+5%	+$11.4K	﹤0.01%	137
2014 Q1	$250K	Buy	4,621 +350	+8%	+$18.1K	﹤0.01%	136
2013 Q4	$204K	Buy	+4,271	New	+$195K	﹤0.01%	142

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ruane, Cunniff & Goldfarb's MRK Position: Q3 2016 in Review

Ruane, Cunniff & Goldfarb sold out of Merck (MRK) in Q3 2016, closing a stake of 4,172 shares — an estimated $229K sold.

Ruane, Cunniff & Goldfarb first reported a position in MRK in Q4 2013 and held it in 11 quarters. The position peaked at $284K in Q3 2014. 1,814 funds tracked by Wall St. Rank hold MRK as of Q3 2016.

Ruane, Cunniff & Goldfarb reported no remaining Merck position as of Q3 2016 after selling out during the quarter.
Ruane, Cunniff & Goldfarb sold 4,172 Merck shares in Q3 2016, an estimated $229K.
Ruane, Cunniff & Goldfarb first reported a position in Merck in Q4 2013 and held it in 11 quarters.
Ruane, Cunniff & Goldfarb's Merck position peaked at $284K in Q3 2014.
1,814 funds tracked by Wall St. Rank held Merck as of Q3 2016.

Based on Ruane, Cunniff & Goldfarb's 13F filing for Q3 2016, filed 14 Nov 2016.